A Massachusetts-based drug manufacturer called Ameridose, which is linked to the pharmacy behind a deadly fungal meningitis outbreak, has recalled all of its products over safety concerns.
Although there was no specific evidence that any of the medications Ameridose produces were contaminated, federal and state regulators raised concerns about the adequacy of the testing processes that are supposed to ensure those medications are sterile, the New York Times reports.
Ameridose is the sister company of the New England Compounding Center, the specialty pharmacy behind the meningitis outbreak that has sickened 377 patients and killed 28 in 19 states, according to the U.S. Centers for Disease Control and Prevention.
Meningitis is an inflammation of the tissue surrounding the spinal cord and brain. The national outbreak has been traced to a fungus contaminating some steroid medication that NECC produced.
The New York Times says Ameridose is a major supplier of sterile injectable medications to hospitals across the country — selling more than 2,200 blended drug products, including tranquilizers, anesthetics and antibiotics.
Lopez McHugh is investigating cases related to this outbreak. If you or a loved one had an injection and were diagnosed with meningitis, you should consult with a Lopez McHugh lawyer for a free consultation.
See a list of Ameridose products here:
See the New York Times story here:
